Your browser doesn't support javascript.
loading
Mechanism-Based Inactivation of Mycobacterium tuberculosis Isocitrate Lyase 1 by (2R,3S)-2-Hydroxy-3-(nitromethyl)succinic acid.
Mellott, Drake M; Torres, Dan; Krieger, Inna V; Cameron, Scott A; Moghadamchargari, Zahra; Laganowsky, Arthur; Sacchettini, James C; Meek, Thomas D; Harris, Lawrence D.
Affiliation
  • Mellott DM; Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843, United States.
  • Torres D; The Ferrier Research Institute, Victoria University of Wellington, Wellington 5046, New Zealand.
  • Krieger IV; Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843, United States.
  • Cameron SA; The Ferrier Research Institute, Victoria University of Wellington, Wellington 5046, New Zealand.
  • Moghadamchargari Z; The Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland 1010, New Zealand.
  • Laganowsky A; Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States.
  • Sacchettini JC; Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States.
  • Meek TD; Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843, United States.
  • Harris LD; Department of Chemistry, Texas A&M University, College Station, Texas 77843, United States.
J Am Chem Soc ; 143(42): 17666-17676, 2021 10 27.
Article in En | MEDLINE | ID: mdl-34664502
ABSTRACT
The isocitrate lyase paralogs of Mycobacterium tuberculosis (ICL1 and 2) are essential for mycobacterial persistence and constitute targets for the development of antituberculosis agents. We report that (2R,3S)-2-hydroxy-3-(nitromethyl)succinic acid (5-NIC) undergoes apparent retro-aldol cleavage as catalyzed by ICL1 to produce glyoxylate and 3-nitropropionic acid (3-NP), the latter of which is a covalent-inactivating agent of ICL1. Kinetic analysis of this reaction identified that 5-NIC serves as a robust and efficient mechanism-based inactivator of ICL1 (kinact/KI = (1.3 ± 0.1) × 103 M-1 s-1) with a partition ratio <1. Using enzyme kinetics, mass spectrometry, and X-ray crystallography, we identified that the reaction of the 5-NIC-derived 3-NP with the Cys191 thiolate of ICL1 results in formation of an ICL1-thiohydroxamate adduct as predicted. One aspect of the design of 5-NIC was to lower its overall charge compared to isocitrate to assist with cell permeability. Accordingly, the absence of the third carboxylate group will simplify the synthesis of pro-drug forms of 5-NIC for characterization in cell-infection models of M. tuberculosis.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Succinates / Enzyme Inhibitors / Isocitrate Lyase / Mycobacterium tuberculosis Type of study: Prognostic_studies Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Succinates / Enzyme Inhibitors / Isocitrate Lyase / Mycobacterium tuberculosis Type of study: Prognostic_studies Language: En Year: 2021 Type: Article